FilingSEC EDGAR6-K
Satellos Bioscience to Host Investor Call on BASECAMP Phase 2 Clinical Strategy
· SEC accepted
StagePhase 2
Filing content
Satellos Bioscience will host a conference call on November 6, 2026, at 8:00 a.m. ET to provide an update on the clinical and regulatory strategy for its BASECAMP Phase 2 pediatric study.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…